Join
Live feed
·
PRReleasevia Quantisnow
KALA BIO Inc. logo

Red Light Holland Engages Kala Bio's Researgency.AI Platform to Support Clinical Development of Filament's Patented PEX010 Botanical Psilocybin Drug Candidate

ByQuantisnow·Wall Street's wire, on your screen.
KALA· KALA BIO Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KALA (KALA BIO Inc.) and more on Quantisnow.